Editas Medicine, Inc. (EDIT)
3.00
-0.11
(-3.54%)
USD |
NASDAQ |
Aug 24, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Market Cap : 460.59M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 460.59M |
| August 21, 2026 | 477.48M |
| August 20, 2026 | 451.38M |
| August 19, 2026 | 498.98M |
| August 18, 2026 | 442.17M |
| August 17, 2026 | 436.03M |
| August 14, 2026 | 432.96M |
| August 13, 2026 | 431.42M |
| August 12, 2026 | 436.03M |
| August 11, 2026 | 452.92M |
| August 10, 2026 | 431.42M |
| August 07, 2026 | 442.17M |
| August 06, 2026 | 445.24M |
| August 05, 2026 | 422.21M |
| August 04, 2026 | 425.28M |
| August 03, 2026 | 406.86M |
| July 31, 2026 | 252.50M |
| July 30, 2026 | 263.26M |
| July 29, 2026 | 254.45M |
| July 28, 2026 | 256.41M |
| July 27, 2026 | 262.28M |
| July 24, 2026 | 254.45M |
| July 23, 2026 | 267.18M |
| July 22, 2026 | 272.07M |
| July 21, 2026 | 282.84M |
| Date | Value |
|---|---|
| July 20, 2026 | 281.86M |
| July 17, 2026 | 291.64M |
| July 16, 2026 | 281.86M |
| July 15, 2026 | 297.52M |
| July 14, 2026 | 309.26M |
| July 13, 2026 | 309.26M |
| July 10, 2026 | 319.05M |
| July 09, 2026 | 322.96M |
| July 08, 2026 | 359.17M |
| July 07, 2026 | 367.00M |
| July 06, 2026 | 357.21M |
| July 02, 2026 | 357.21M |
| July 01, 2026 | 321.00M |
| June 30, 2026 | 317.09M |
| June 29, 2026 | 313.17M |
| June 26, 2026 | 278.92M |
| June 25, 2026 | 268.16M |
| June 24, 2026 | 274.03M |
| June 23, 2026 | 270.11M |
| June 22, 2026 | 274.03M |
| June 18, 2026 | 263.26M |
| June 17, 2026 | 249.56M |
| June 16, 2026 | 230.97M |
| June 15, 2026 | 240.75M |
| June 12, 2026 | 244.67M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Geron Corp. | 976.55M |
| Novavax, Inc. | 1.460B |
| Recursion Pharmaceuticals, Inc. | 1.736B |
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 239.94B |
Market Cap Related Metrics
| PS Ratio | 6.454 |
| Price to Book Value | 4.375 |
| Price | 3.00 |
| Earnings Yield | -24.82% |